The wire › SEC Form 8-K
SANGAMO THERAPEUTICS, INC SGMO
Filed with the SEC on Jun 23, 2026. Reported event date Jun 18, 2026.
- Business address
- Richmond, CA
- State
- California
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2836)
- SEC CIK
- 1001233
- Accession number
- 0001193125-26-278582
Items reported in this filing
- Item 1.01 Entry into a Material Definitive Agreement
- Item 1.03 Bankruptcy or Receivership
A bankruptcy case or a receivership has started for the company or one of its main subsidiaries: the company itself reports it on Form 8-K Item 1.03.
- Item 2.03 Creation of a Direct Financial Obligation
- Item 2.05 Costs Associated with Exit or Disposal Activities
The company reported a restructuring: it committed to exit or dispose of part of its business (for example closing some sites, ending a product line or cutting staff) and expects material costs, under Form 8-K Item 2.05. It does not mean the company is closing; healthy, profitable companies file it too, often alongside an earnings release.
Other entries on the wire for this company
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing